Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - metforminum - compresse rivestite con film - metformini hydrochloridum 850.0 mg corrisp. metformin 662.9 mg, povidonum k 30, magnesii stearas, placcatura: hypromellosum pro compresso obducto. - farmaco antidiabetico orale - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - metformini hydrochloridum - compresse rivestite con film - metformini hydrochloridum 1000.0 mg corrisp. metforminum 780.0 mg, povidonum k 30, magnesio stearas, Überzug: hypromellosum, macrogolum 400, macrogolum 8000 per compresso haze. - farmaco antidiabetico orale - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - metronidazolum - compresse rivestite con film - metronidazolum 250 mg, excipiens pro compresso obducto. - malattie infettive causate da batteri anaerobici o protozoi - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - metronidazolum - compresse rivestite con film - metronidazolum 500 mg, excipiens pro compresso obducto. - malattie infettive causate da batteri anaerobici o protozoi - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - metronidazolum - ovuli - metronidazolum 500 mg, excipiens pro asteraceae ha. - infezione da batteri anaerobici e protozoi - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - glibenclamidum - compresse - glibenclamidum 5 mg, lactosum 79 mg, maydis amylum, talcum, silica colloidalis anhydrica, magnesii stearas pro compresso. - il diabete orale - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - capsule rigide - clindamycinum 150 mg ut clindamycini hydrochloridum, maydis amylum, talcum, magnesii stearas, lactosum monohydricum max. 224.13 mg, kapselhülle: gelatina, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - malattie infettive - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - capsule rigide - clindamycinum 300 mg ut clindamycini hydrochloridum, maydis amylum, talcum, magnesii stearas, lactosum monohydricum max. 283.27 mg, kapselhülle: gelatina, e 171, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - malattie infettive - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

eumedica pharmaceuticals ag - sulfamethoxazolum, trimethoprimum - concentrato per soluzione per infusione - sulfamethoxazolum 400.0 mg, trimethoprimum 80.0 mg, propylenglycolum 2050.0 mg, natrii hydroxidum, ethanolaminum, ethanolum 500.0 mg corresp. ethanolum 12.7 % v/v, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp. natrium 34 mg. - malattie infettive - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - granulato per la realizzazione di una soluzione orale - clindamycinum 75 mg ut clindamycini-2 palmitatis hydrochloridum, simeticonum, poloxamerum 188, saccharum 1.8 g, aromatica (kirschen), e 214 0.6 mg ad granulatum corresp. solutio reconstituta 5 ml. - malattie infettive - synthetika